Real-time enrollment status for this non-small cell lung cancer with mutation in epidermal growth factor receptor clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 2:22 AM UTC
| NCT Number | NCT07874490 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT07874490 is currently recruiting participants. This phase2 study for non-small cell lung cancer with mutation in epidermal growth factor receptor is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07874490 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07874490 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.